Anti-CRISPR Small Molecule Discovered Using New High-Throughput Screening Platform

May 02, 2019

|

NEW YORK (GenomeWeb) – A team led by researchers at the Broad Institute and Brigham and Women's Hospital has developed a high-throughput platform for identifying small molecules that can disrupt the genome editing activity of CRISPR-Cas nucleases.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Breaking News

The Scan

Biden Cancer Initiative Suspends Work

The nonprofit Biden Cancer Initiative is suspending its operations, according to the Associated Press.

Not What Was Expected, Eh?

Researchers examine how white nationalists handle personal genetic ancestry results that conflict with their racist worldview, the New York Times reports.

And Now You Know

NPR speaks with research participants before and after they learn their APOE E4 status, which affects their risk of developing Alzheimer's disease.

PLOS Papers Tackle Toxoplasma in Senegal, CCHFV in Sudan, More

In PLOS this week: genetic characterization of Toxoplasma gondii strains, Crimean-Congo Hemorrhagic Fever Virus uncovered in Sudan, and more.

Featured White Papers

Cell Engineering 101

Improved CRISPR Knockout Efficiency Using an Automated Optimization Workflow

CRISPR 101

Gene Knockouts: How CRISPR Is Used to Inactivate Genes

Aug

28

Featured Webinar

Beyond Cas9: CRISPR Gene Editing with Alternative Nucleases

This webinar will provide an overview of alternatives to the popular Cas9 nuclease used in CRISPR gene editing.

Menu